Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Alisporivir results in hepatitis C virus genotypes 1, 2 and 3 reported

May 21, 2012

Daclatasvir shows promise in difficult-to-treat populations

May 21, 2012

In vivo studies show new therapeutic potential for CDDO-Me

May 21, 2012

Promising results reported for first patients in phase I trial of VRX-007

May 21, 2012

Data reported on effects of HSC gene therapy for metachromatic leukodystrophy

May 21, 2012

Follow-up of AAV2-FIX study patients shows low risk of insertional mutagenesis

May 18, 2012

hMaxi-K gene transfer appears safe in women with overactive bladder

May 18, 2012

Positive phase I results presented for Achillion's NS5A inhibitor

May 18, 2012

Abbott presents clinical results for their antiviral candidate ABT-072

May 17, 2012

First results for phase II COMPLETE study of eculizumab presented

May 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...